Allianz Asset Management GmbH - SAREPTA THERAPEUTICS INC ownership

SAREPTA THERAPEUTICS INC's ticker is and the CUSIP is 803607AB6. A total of 37 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Allianz Asset Management GmbH ownership history of SAREPTA THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$22,610,000
-13.2%
17,960,000
-10.0%
0.02%
+10.5%
Q1 2022$26,058,000
-40.3%
19,960,000
-33.2%
0.02%
-36.7%
Q4 2021$43,664,000
-46.8%
29,900,000
-10.9%
0.03%
-63.0%
Q4 2020$82,089,000
-3.3%
33,560,000
-16.8%
0.08%
-18.2%
Q3 2020$84,921,000
-10.7%
40,360,000
-2.0%
0.10%
-10.0%
Q2 2020$95,113,000
+54.2%
41,190,000
+2.4%
0.11%
+32.5%
Q1 2020$61,673,000
-56.7%
40,240,000
-43.5%
0.08%
-36.2%
Q4 2019$142,581,000
+137.1%
71,210,000
+56.6%
0.13%
+120.3%
Q3 2019$60,133,00045,460,0000.06%
Other shareholders
SAREPTA THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 88,657,000$148,264,0002.95%
DeepCurrents Investment Group LLC 45,997,000$76,672,0002.94%
TENOR CAPITAL MANAGEMENT Co., L.P. 38,394,000$64,158,0001.47%
WOLVERINE ASSET MANAGEMENT LLC 71,012,000$118,356,0001.28%
Opti Capital Management, LP 3,000,000$5,013,0000.46%
MIZUHO SECURITIES USA LLC 1,663,000$2,766,0000.38%
Verition Fund Management LLC 25,954,000$21,680,6590.24%
Aequim Alternative Investments LP 5,000,000$8,345,0000.24%
PALISADE CAPITAL MANAGEMENT, LP 3,831,000$6,522,0000.18%
LORD, ABBETT & CO. LLC 23,424,000$39,095,0000.14%
View complete list of SAREPTA THERAPEUTICS INC shareholders